Jp. Wang et al., INHIBITION OF HIND-PAW EDEMA AND CUTANEOUS VASCULAR PLASMA EXTRAVASATION IN MICE BY ACETYLSHIKONIN, European journal of pharmacology, 272(1), 1995, pp. 87-95
Acetylshikonin, a naphthoquinone isolated from the Chinese herb medici
ne, tzu ts'ao, was demonstrated to inhibit the polymyxin B-induced hin
d-paw edema in normal as well as in adrenalectomized mice. Liver glyco
gen content was increased in adrenalectomized mice pretreated with dex
amethasone, but not with acetylshikonin. Like diphenhydramine, methyse
rgide and isoproterenol, acetylshikonin reduced the plasma exudation e
voked in dorsal hind-paw skin by antidromic stimulation of the sapheno
us nerve, and in passive cutaneous anaphylactic reaction, bradykinin-,
substance P-, compound 48/80-, histamine- and serotonin-induced ear e
dema. Indomethacin was ineffective in these respects. Bradykinin- and
substance P-induced plasma exudation were also significantly reduced w
hen [Thi(5,8),D-phe(7)]bradykinin and [D-Pro(2),D-Trp(7,9)]substance P
were coinjected with bradykinin and substance P, respectively. In iso
lated rat peritoneal mast cell preparation, acetylshikonin produced a
concentration-dependent inhibition of histamine and beta-glucuronidase
release from mast cells challenged by compound 48/80. In compound 48/
80-pretreated mice, acetylshikonin and isoproterenol produced signific
antly more inhibitory effect on bradykinin- and substance P-induced pl
asma exudation than did diphenhydramine in combination with methysergi
de. Pretreatment with diphenhydramine/methysergide in compound 48/80-p
retreated mice significantly further reduced the bradykinin- and subst
ance P-induced plasma exudation if [Thi(5,8),D-Phe(7)]bradykinin and [
D-Pro(2),D-Trp(7,9)]substance P were coinjected with bradykinin or sub
stance P, respectively. The results suggest that the inhibitory effect
of acetylshikonin on the edematous response is due neither to the rel
ease of steroid hormones from the adrenal gland nor to the glucocortic
oid activity, but probably partly to the suppression of mast cell degr
anulation and partly to protection of the vasculature from mediator ch
allenge.